214 related articles for article (PubMed ID: 37604683)
21. Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause.
Kastritis E; Kanellias N; Theodorakakou F; Psimenou E; Gakiopoulou C; Marinaki S; Roussou M; Gavriatopoulou M; Migkou M; Fotiou D; Eleutherakis-Papaiakovou E; Malandrakis P; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2020 Dec; 61(13):3247-3250. PubMed ID: 32716220
[No Abstract] [Full Text] [Related]
22. Does my patient with a serum monoclonal spike have multiple myeloma?
Bianchi G; Ghobrial IM
Hematol Oncol Clin North Am; 2012 Apr; 26(2):383-93, ix. PubMed ID: 22463833
[TBL] [Abstract][Full Text] [Related]
23. hMLH1 and MGMT inactivation as a mechanism of tumorigenesis in monoclonal gammopathies.
Martin P; Santón A; García-Cosio M; Bellas C
Mod Pathol; 2006 Jul; 19(7):914-21. PubMed ID: 16607377
[TBL] [Abstract][Full Text] [Related]
24. [Monoclonal gammopathy of (un)known significance].
Steinhardt M; Kortüm M; Einsele H; Rasche L
Dtsch Med Wochenschr; 2022 Jun; 147(11):675-682. PubMed ID: 35636418
[TBL] [Abstract][Full Text] [Related]
25. Differential diagnosis of monoclonal gammopathy.
Gandara DR; Mackenzie MR
Med Clin North Am; 1988 Sep; 72(5):1155-67. PubMed ID: 3137401
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal gammopathy of uncertain significance.
Alejo E; Puertas B; Mateos MV
Med Clin (Barc); 2023 Sep; 161(5):217-224. PubMed ID: 37330390
[TBL] [Abstract][Full Text] [Related]
27. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
28. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
Fend F; Dogan A; Cook JR
Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
[TBL] [Abstract][Full Text] [Related]
29. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
[TBL] [Abstract][Full Text] [Related]
30. New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.
Kapoulas S; Raptis V; Papaioannou M
Nephrol Ther; 2015 Jun; 11(3):135-43. PubMed ID: 25861714
[TBL] [Abstract][Full Text] [Related]
31. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance].
Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S
Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review.
Kaur J; Valisekka SS; Hameed M; Bandi PS; Varma S; Onwughalu CJ; Ibrahim H; Mongia H
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):e195-e212. PubMed ID: 36966041
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal gammopathy-associated pure red cell aplasia.
Korde N; Zhang Y; Loeliger K; Poon A; Simakova O; Zingone A; Costello R; Childs R; Noel P; Silver S; Kwok M; Mo C; Young N; Landgren O; Sloand E; Maric I
Br J Haematol; 2016 Jun; 173(6):876-83. PubMed ID: 26999424
[TBL] [Abstract][Full Text] [Related]
34. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.
Ermak N; Nguyen-Khoa T; Alyanakian MA
Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674
[TBL] [Abstract][Full Text] [Related]
35. [Urinary investigations in the diagnosis and monitoring of monoclonal gammopathies in daily practice].
Oudart JB; Quinquenel A; Lavalard E; Schneider N; Fromonot J; Ramont L; Maquart FX
Ann Biol Clin (Paris); 2014; 72(2):147-52. PubMed ID: 24736135
[TBL] [Abstract][Full Text] [Related]
36. [Spectrum of monoclonal gammopathies].
Matuszkiewicz-Rowińska J; Wieliczko M
Wiad Lek; 2017; 70(6 pt 2):1170-1174. PubMed ID: 29533907
[TBL] [Abstract][Full Text] [Related]
37. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
38. Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.
Burgos L; Tamariz-Amador LE; Puig N; Cedena MT; Guerrero C; Jelínek T; Johnson S; Milani P; Cordon L; Perez JJ; Lasa M; Termini R; Oriol A; Hernandez MT; Palomera L; Martinez-Martinez R; de la Rubia J; de Arriba F; Rios R; Gonzalez ME; Gironella M; Cabañas V; Casanova M; Krsnik I; Perez-Montaña A; González-Calle V; Rodriguez-Otero P; Maisnar V; Hajek R; Van Rhee F; Jimenez-Zepeda V; Palladini G; Merlini G; Orfao A; de la Cruz J; Martinez-Lopez J; Lahuerta JJ; Rosiñol L; Blade J; Mateos MV; San-Miguel JF; Paiva B;
J Clin Oncol; 2023 Jun; 41(16):3019-3031. PubMed ID: 36930848
[TBL] [Abstract][Full Text] [Related]
39. [Monoclonal gammopathy of undetermined significance and monoclonal B-lymphocytosis].
Hübel K; Hallek M
Internist (Berl); 2013 Jun; 54(6):709-14. PubMed ID: 23670732
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
